SIRPA and neoplasm: Blockade of SIRPA rescues the expression of Dectin1/chemokines/cytokines by ID3‐ deficient KCs, thereby restoring the peritumoral anti‐tumor niche mediated by KCs, including the recruitment and activation of CD8+ T and NK cells.